skinny.

Latest / Parkinson's Disease Education Podcast

A Shocking New Treatment for Parkinson's: How LESS Dopamine Could Halt Progression

Could a simple drug intended to treat cancer treatment complications be the next big breakthrough in Parkinson's Disease treatment? Dr. Jonathan Sackner-Bernstein, MD, is leading research on tyrosine hydroxylase inhibition as a novel approach to managing Parkinson's symptoms and slowing disease progression. Unlike traditional treatments that focus solely on replacing lost dopamine, a previously FDA approved drug (RB-190) targets tyrosine hydroxylase (TH)—the enzyme responsible for dopamine production—offering a new way to reduce dyskinesias, oxidative stress, and dopamine imbalances in the…

Log in to save or queue this episode.

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.